Vicks huddles up with Drew Brees to find most dedicated NFL fan
CINCINNATI — Procter & Gamble brands Vicks DayQuil and Vicks NyQuil last week kicked off its “Search for the Most Dedicated NFL Fan” — a new Facebook contest featuring two tickets to Super Bowl XLV as the top prize.
P&G has partnered with New Orleans Saints quarterback Drew Brees to help get the word out about the contest.
Fans who visit Facebook.com/NyQuil will choose the finalist they feel is most deserving of the two Super Bowl tickets and embodies the spirit of the most dedicated fan among 32 fan finalists, one from each NFL team.
The grand-prize winner of “Vicks NyQuil/DayQuil Search for the Most Dedicated NFL Fan” contest will be announced on Jan. 13.
Vicks is a sponsor of the National Football League and Super Bowl XLV.
IWPR: Affordable Care Act provision to drive breast-feeding rates up 4%
WASHINGTON — According to a new report released Friday by the Institute for Women’s Policy Research, a provision in the Affordable Care Act of 2010 that requires employers to provide nursing breaks and a private, sanitary place to express breast milk for most mothers employed on an hourly basis will drive breast-feeding rates up by 4% in the first six months. That translates into as many as 165,000 new moms breast-feeding each year, or more than 1 million new moms in six years, noted Robert Drago, director of research with IWPR.
The ACA provisions for breast-feeding cover three-fifths of employed women living in families below 350% of the government poverty line (about $50,000 for a family of two). That’s especially important because it includes a large number of hourly employees — a group that has been historically low in breast-feeding, Drago said.
All told, 19 million women of breast-feeding age will benefit from the new breast-feeding protections, Drago said.
Prestige Brands to acquire Dramamine from McNeil Consumer Healthcare
IRVINGTON, N.Y. — Prestige Brands Holdings on Thursday announced that it has entered into a definitive agreement to acquire the assets associated with the Dramamine business in the United States from McNeil Consumer Healthcare for $76 million in cash.
“The company expects to quickly and smoothly integrate Dramamine into the Prestige portfolio and drive growth through enhanced brand support,” stated Matthew Mannelly, Prestige Brands CEO.
The transaction is expected to close prior to the end of January subject to customary closing conditions.
Dramamine is the market leader in the over-the-counter motion-sickness category in the United States, with an estimated market share of approximately 32%, Prestige reported. Dramamine products are used for the prevention and treatment of nausea, vomiting and dizziness symptoms associated with motion sickness.